Generic Injectables Market by Player, Region, Type, Application and Sales Channel 2024-2030
The global Generic Injectables market was valued at US$ 160.3 billion in 2023 and is projected to reach US$ 222.6 billion by 2030, at a CAGR of 5.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report studies the Generic Injectables market, covering market size for segment by type (Small Molecules, Large Molecules, etc.), by application (Oncology, Anesthesia, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Hospira (Pfizer), Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals, Dr. Reddy?s Laboratories, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).

Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/generic-injectables-2024-2030-61

This report provides detailed historical analysis of global market for Generic Injectables from 2018-2023, and provides extensive market forecasts from 2024-2032 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Generic Injectables market.

Leading Players of Generic Injectables including:

Hospira (Pfizer)
Fresenius Kabi
Sandoz (Novartis)
Hikma Pharmaceuticals
Dr. Reddy?s Laboratories
Grifols
Nichi-Iko Group (Sagent)
Teva Pharmaceutical
Auromedics
Sanofi
Claris Injectables (Baxter)
Gland Pharma
Endo International
Lupin Pharmaceuticals

Market split by Type:

Small Molecules
Large Molecules

Market split by Application:

Oncology
Anesthesia
Anti-Infectives
Parenteral Nutrition
Cardiovascular Diseases

Market split by Sales Channel:

Direct Channel
Distribution Channel

Market split by Region/Country:

North America (United States and Canada)
Europe (Germany, UK, France, Italy, Spain, and Russia, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia, etc.)
South America (Brazil, Mexico, and Argentina, etc.)
Middle East & Africa (Turkey, UAE, Saudi Arabia, and South Africa, etc.)

If you have any special requirements, please let us know and we can provide you the customized report as you want.

Get the Complete Report & TOC @ https://www.grandresearchstore.com/life-sciences/generic-injectables-2024-2030-61

CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1)332 2424 294 / 646 781 7170 / +91 8087042414

Follow Us On linkedin :- https://www.linkedin.com/company/grand-research-store/
